Waldenström's Macroglobulinemia
The Bing Center for Waldenström's macroglobulinemia provides comprehensive, state-of-the-art care, including promising new therapies through clinical trials, to patients with Waldenström's macroglobulinemia and related IgM disorders.
Each patient's care combines the finest treatments currently available for Waldenström's macroglobulinemia with innovative new therapies based on research discovered through the collaboration of the center's laboratories and many other scientists from around the world.
The Bing Center for Waldenström's macroglobulinemia encompasses a large, international team of laboratory-based and clinical investigators who are striving to find more effective therapies for Waldenström's macroglobulinemia and, someday, a cure.
Our Services
The Bing Center for Waldenström's macroglobulinemia provides a comprehensive range of services for patients with Waldenström's macroglobulinemia, including:
- Consultation
- Evaluations
- Diagnosis (pathologic)
- Second opinions
- Development of a personalized treatment plan offering the latest therapies (chemotherapy, biological therapies)
- Access to clinical trials offering novel therapies
- Stem cell transplantation
- Follow-up care
- Access to complementary therapies through the Leonard P. Zakim Center for Integrated Therapies
Clinical Research
The Center offers patients access to a wide range of clinical research trials. These include studies aimed at improving the outcomes of patients undergoing biological therapies using agents in trials such as Rituxan and bortezomib that attempt to kill Waldenström's macroglobulinemia tumor cells directly. The center also has clinical research trials evaluating supportive therapies like statins and phosphodiesterase inhibitors to help understand the mechanics of the disease.
The main goal of clinical research at the Bing Center for Waldenström's macroglobulinemia is to swiftly and efficiently take discoveries made in the laboratory to the clinic where they can benefit the health and well-being of the patient.
